Padeliporfin

Tookad 183 MG Polvo Para Solucion Inyectable

183 mg polvo para solución inyectableSpainAuthorisedAuthorised 28 Mar 2019

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

TookadEuropean UnionAuthorised

TookadEuropean Union · STEBA Biotech S.ASame brand
TookadCroatiaSame brand
TookadItaly · Polvere per soluzione iniettabile · Steba Biotech S.A.Same brand
Tookad 200 mg poeder voor oplossing voor injectieNetherlands · Poeder voor oplossing voor injectie · Steba Biotech S.A.Same brand
Tookad 400 mg poeder voor oplossing voor injectieNetherlands · Poeder voor oplossing voor injectie · Steba Biotech S.A.Same brand

Packs

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Padeliporfin

Tookad 183 MG Polvo Para Solucion Inyectable

183 mg polvo para solución inyectableSpainAuthorisedAuthorised 28 Mar 2019

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

TookadEuropean UnionAuthorised

Packs

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Padeliporfin
Strength: 183 mg
Dosage form: polvo para solución inyectable
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Authorised
Status in the register: Autorizado, no comercializado
Authorised: 28 Mar 2019
Registration: 1171228001
Marketing authorisation holder: Steba Biotech S.A.
Procedure: EU centralised
Supply: Uso Hospitalario
EU number: EU/1/17/1228